T. Aaes‐Jørgensen

1.0k total citations
24 papers, 820 citations indexed

About

T. Aaes‐Jørgensen is a scholar working on Psychiatry and Mental health, Organic Chemistry and Pharmacology. According to data from OpenAlex, T. Aaes‐Jørgensen has authored 24 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in T. Aaes‐Jørgensen's work include Schizophrenia research and treatment (5 papers), Epilepsy research and treatment (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). T. Aaes‐Jørgensen is often cited by papers focused on Schizophrenia research and treatment (5 papers), Epilepsy research and treatment (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). T. Aaes‐Jørgensen collaborates with scholars based in Denmark and United States. T. Aaes‐Jørgensen's co-authors include Søren H. Sindrup, Kim Brøsen, K. Fredricson Overø, M. G. J. Hansen, L. F. Gram, Lars F. Gram, A. Dejgaard, Ulla Bjerre, Ove Svendsen and Klaus P. Bøgesø and has published in prestigious journals such as Psychopharmacology, Clinical Pharmacology & Therapeutics and Acta Psychiatrica Scandinavica.

In The Last Decade

T. Aaes‐Jørgensen

24 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Aaes‐Jørgensen Denmark 13 270 249 200 193 123 24 820
P. R. Bieck Germany 19 225 0.8× 310 1.2× 165 0.8× 125 0.6× 320 2.6× 73 1.2k
K. H. Antonin Germany 16 261 1.0× 203 0.8× 142 0.7× 66 0.3× 226 1.8× 36 954
Barry D. Zussman United Kingdom 15 253 0.9× 344 1.4× 218 1.1× 107 0.6× 138 1.1× 20 915
J S Harmatz United States 16 228 0.8× 192 0.8× 336 1.7× 67 0.3× 123 1.0× 22 1.0k
Bo Siwers Sweden 17 292 1.1× 256 1.0× 170 0.8× 55 0.3× 228 1.9× 23 865
Niels‐Erik Larsen Denmark 20 384 1.4× 245 1.0× 94 0.5× 77 0.4× 96 0.8× 44 1.1k
K. Otani Japan 18 432 1.6× 251 1.0× 257 1.3× 85 0.4× 279 2.3× 49 1.1k
Richard E. Gammans United States 19 162 0.6× 232 0.9× 135 0.7× 63 0.3× 237 1.9× 42 1.6k
Takao Aoyama Japan 16 168 0.6× 259 1.0× 105 0.5× 109 0.6× 163 1.3× 72 957
C. Barnas Austria 19 700 2.6× 197 0.8× 168 0.8× 65 0.3× 166 1.3× 61 1.2k

Countries citing papers authored by T. Aaes‐Jørgensen

Since Specialization
Citations

This map shows the geographic impact of T. Aaes‐Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Aaes‐Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Aaes‐Jørgensen more than expected).

Fields of papers citing papers by T. Aaes‐Jørgensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Aaes‐Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Aaes‐Jørgensen. The network helps show where T. Aaes‐Jørgensen may publish in the future.

Co-authorship network of co-authors of T. Aaes‐Jørgensen

This figure shows the co-authorship network connecting the top 25 collaborators of T. Aaes‐Jørgensen. A scholar is included among the top collaborators of T. Aaes‐Jørgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Aaes‐Jørgensen. T. Aaes‐Jørgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joffe, Preben, et al.. (1998). Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects. European Journal of Clinical Pharmacology. 54(3). 237–242. 50 indexed citations
2.
Solgaard, Torfinn, et al.. (1994). Zuclopenthixol Decanoate in Maintenance Treatment of Schizophrenic Outpatients. Pharmacopsychiatry. 27(3). 119–123. 12 indexed citations
3.
Sindrup, Søren H., Kim Brøsen, M. G. J. Hansen, et al.. (1993). Pharmacokinetics of Citalopram in Relation to the Sparteine and the Mephenytoin Oxidation Polymorphisms. Therapeutic Drug Monitoring. 15(1). 11–17. 180 indexed citations
4.
Gram, L. F., M. G. J. Hansen, Søren H. Sindrup, et al.. (1993). Citalopram. Therapeutic Drug Monitoring. 15(1). 18–24. 75 indexed citations
5.
Sindrup, Søren H., Ulla Bjerre, A. Dejgaard, et al.. (1992). The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clinical Pharmacology & Therapeutics. 52(5). 547–552. 228 indexed citations
6.
Gerlach, Jes, et al.. (1991). Perphenazine decanoate andcis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Psychopharmacology. 105(1). 42–48. 26 indexed citations
7.
Aaes‐Jørgensen, T.. (1989). Pharmacokinetics of three different injectable zuclopenthixol preparations. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 13(1-2). 77–85. 21 indexed citations
8.
Kristiansen, Jette E., et al.. (1988). Synergy between a non‐neuroleptic thioxanthene stereo‐isomer and penicillin in vivo. Apmis. 96(7-12). 1079–1084. 13 indexed citations
9.
Aaes‐Jørgensen, T., Hans Liedholm, & Arne Melander. (1987). Influence of food intake on the bioavailability of zuclopenthixol.. PubMed. 5(3). 157–60. 4 indexed citations
10.
Svendsen, Ove, Lars Blom, T. Aaes‐Jørgensen, & Jens‐Jørgen Larsen. (1985). Local Toxicity of Different Drugs after Intramuscular or Intralipomatous Injection in Pigs: Serum Concentrations after Three Different Formulations of cis(Z)–Clopenthixol. Acta Pharmacologica et Toxicologica. 57(2). 78–87. 5 indexed citations
11.
Viala, Alain, et al.. (1984). [Determination of cis(Z)-clopenthixol and fluphenazine in whole blood and plasma by high-performance liquid chromatography with an internal standard].. PubMed. 38(6). 299–303. 2 indexed citations
12.
Aaes‐Jørgensen, T., et al.. (1984). Serumkoncentrationer ved akutte paranoide psykoser behandlet med cis(Z)-clopenthixol. Nordisk Psykiatrisk Tidsskrift. 38(4). 229–233. 4 indexed citations
13.
Aaes‐Jørgensen, T., et al.. (1982). Manibehandling med cis(Z)-clopenthixol (CisordinolR, ClopixolR). Nordisk Psykiatrisk Tidsskrift. 36(6). 321–324. 8 indexed citations
14.
Aaes‐Jørgensen, T., et al.. (1981). Serum levels of the isomers of clopenthixol in patients given cis(Z)‐clopenthixol or cis(Z)/trans(E)‐clopenthixol. Acta Psychiatrica Scandinavica. 64(s294). 70–77. 17 indexed citations
15.
Aaes‐Jørgensen, T.. (1981). Serum concentrations of cis(Z)‐ and trans(E)‐clopenthixol after administration of cis(Z)‐clopenthixol and clopenthixol to human volunteers. Acta Psychiatrica Scandinavica. 64(s294). 64–69. 8 indexed citations
16.
Krogsgaard‐Larsen, Povl, et al.. (1981). THIP, isoguvacine, isoguvacine oxide, and related GABA agonists.. PubMed. 29. 69–76. 17 indexed citations
17.
Aaes‐Jørgensen, T.. (1981). Serum concentrations of cis(Z)- and trans(E)-clopenthixol after administration of cis(Z)-clopenthixol and clopenthixol to human volunteers. Acta Psychiatrica Scandinavica. 64(s294). 64–69. 2 indexed citations
18.
Svendsen, Ove & T. Aaes‐Jørgensen. (1979). Studies on the Fate of Vegetable Oil after Intramuscular Injection into Experimental Animals. Acta Pharmacologica et Toxicologica. 45(5). 352–378. 33 indexed citations
19.
Aaes‐Jørgensen, T. & A. Jørgensen. (1977). Studies of excretion in rabbit milk after administration of carbon-14 labelled amitriptyline and nortriptyline.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 227(2). 294–301. 1 indexed citations
20.
Aaes‐Jørgensen, T., K. Fredricson Overø, Klaus P. Bøgesø, & A. Jørgensen. (1977). Pharmacokinetic Studies on Clopenthixol Decanoate; A Comparison with Clopenthixol in Dogs and Rats. Acta Pharmacologica et Toxicologica. 41(2). 103–120. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. R. Bieck Breakdown of academic impact, for papers by K. H. Antonin Breakdown of academic impact, for papers by Barry D. Zussman Breakdown of academic impact, for papers by J S Harmatz Breakdown of academic impact, for papers by Bo Siwers Breakdown of academic impact, for papers by Niels‐Erik Larsen Breakdown of academic impact, for papers by K. Otani Breakdown of academic impact, for papers by Richard E. Gammans Breakdown of academic impact, for papers by Takao Aoyama Breakdown of academic impact, for papers by C. Barnas
Rankless by CCL
2026